Related Experiment Video
Updated: Jun 25, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review
Ibrahim Tawhari1,2, Samantha Saggese2, Shatha S Alshahrani1
1King Khalid University, Abha, Saudi Arabia.
Abstract:
Achromobacter xylosoxidans is a gram-negative bacterium that is responsible for rare peritonitis associated with peritoneal dialysis (PD). We present a case of a 64-year-old woman with a medical history of end-stage renal disease undergoing PD who was admitted to the emergency department with abdominal pain and nausea. Physical examination and laboratory studies revealed peritoneal signs and laboratory abnormalities consistent with peritonitis. Intraperitoneal catheter dysfunction was identified and subsequently resolved via laparoscopy. Following a peritoneal fluid culture, A xylosoxidans was identified, leading to the initiation of intraperitoneal meropenem treatment. After an initial improvement, the patient developed an ileus and recurrent abdominal symptoms, and further peritoneal cultures remained positive for A xylosoxidans. Subsequent treatment included intravenous meropenem and vancomycin for Clostridium difficile colitis. Owing to the high likelihood of biofilm formation on the PD catheter by A xylosoxidans, the catheter was removed, and the patient transitioned to hemodialysis. Intravenous meropenem was continued for 2 weeks post-catheter removal. This case highlights the challenges in managing recurrent peritonitis in PD patients caused by multidrug-resistant A xylosoxidans. A high index of suspicion, appropriate microbiological identification, and targeted intraperitoneal and systemic antibiotic treatment, along with catheter management, are crucial in achieving a favorable outcome in such cases.
Insights
Achromobacter xylosoxidans peritonitis in peritoneal dialysis (PD) patients is rare. This case highlights challenges in treating recurrent infections caused by multidrug-resistant strains, emphasizing catheter management and targeted antibiotics.
Area of Science:
- Microbiology
- Nephrology
- Infectious Diseases
Background:
- Peritonitis is a serious complication of peritoneal dialysis (PD).
- Achromobacter xylosoxidans, a gram-negative bacterium, is an uncommon cause of PD-associated peritonitis.
- Recurrent or refractory cases pose significant management challenges.
Approach:
- A case study of a 64-year-old female end-stage renal disease patient undergoing PD presenting with peritonitis.
- Initial treatment involved intraperitoneal meropenem after identifying A. xylosoxidans.
- Management was complicated by ileus, recurrent symptoms, and persistent A. xylosoxidans infection.
Key Points:
- The patient experienced recurrent peritonitis due to multidrug-resistant Achromobacter xylosoxidans, complicated by biofilm formation.
- Successful management necessitated catheter removal and transition to hemodialysis.
- Intravenous meropenem was administered post-catheter removal.
Conclusions:
- Managing Achromobacter xylosoxidans peritonitis in PD patients requires a high index of suspicion.
- Prompt microbiological identification and targeted antibiotic therapy are crucial.
- Catheter management, including removal when indicated, is essential for favorable outcomes.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management

